Overview

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza Symptoms

Status:
COMPLETED

Trial end date:
2025-05-08

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety of a single dose baloxavir marboxil compared with 5 days of oseltamivir administered twice a day (BID) in Chinese pediatric participants aged 1 to \< 12 years with influenza symptoms.

Phase:

PHASE3

Details

Lead Sponsor:

Hoffmann-La Roche

Treatments:

baloxavir
Oseltamivir